702 related articles for article (PubMed ID: 26588929)
1. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
Iba T; Thachil J
Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
[TBL] [Abstract][Full Text] [Related]
2. Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity.
Iba T; Di Nisio M; Thachil J; Wada H; Asakura H; Sato K; Kitamura N; Saitoh D
Crit Care; 2016 Sep; 20():287. PubMed ID: 27629997
[TBL] [Abstract][Full Text] [Related]
3. Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study.
Umemura Y; Yamakawa K; Hayakawa M; Kudo D; Fujimi S
Clin Appl Thromb Hemost; 2018 Jul; 24(5):734-740. PubMed ID: 29471674
[TBL] [Abstract][Full Text] [Related]
4. Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
Murao A; Kato T; Yamane T; Honda G; Eguchi Y
Clin Appl Thromb Hemost; 2022; 28():10760296221077096. PubMed ID: 35166576
[TBL] [Abstract][Full Text] [Related]
5. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
[TBL] [Abstract][Full Text] [Related]
7. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of combined antithrombin and thrombomodulin therapy on in-hospital mortality in mechanically ventilated septic patients with disseminated intravascular coagulation.
Umegaki T; Kunisawa S; Nishimoto K; Kamibayashi T; Imanaka Y
Sci Rep; 2020 Mar; 10(1):4874. PubMed ID: 32184456
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.
Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F
Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812
[TBL] [Abstract][Full Text] [Related]
12. The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation.
Iba T; Nagaoka I; Boulat M
Thromb Res; 2013 May; 131(5):383-9. PubMed ID: 23566533
[TBL] [Abstract][Full Text] [Related]
13. New therapeutic options for patients with sepsis and disseminated intravascular coagulation.
Iba T; Yamada A; Hashiguchi N; Nagaoka I
Pol Arch Med Wewn; 2014; 124(6):321-8. PubMed ID: 24732306
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan.
Taniguchi K; Ohbe H; Yamakawa K; Matsui H; Fushimi K; Yasunaga H
BMC Cancer; 2020 Sep; 20(1):867. PubMed ID: 32907555
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Saitoh D; Gando S; Thachil J
Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan.
Iba T; Gando S; Thachil J
J Thromb Haemost; 2014 Jul; 12(7):1010-9. PubMed ID: 24801203
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure.
Kuroda H; Masuda Y
Clin Appl Thromb Hemost; 2020; 26():1076029620981630. PubMed ID: 33332196
[TBL] [Abstract][Full Text] [Related]
19. Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis.
Wada T; Yamakawa K; Kabata D; Abe T; Ogura H; Shiraishi A; Saitoh D; Kushimoto S; Fujishima S; Mayumi T; Hifumi T; Shiino Y; Nakada TA; Tarui T; Otomo Y; Okamoto K; Umemura Y; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S; Gando S
Sci Rep; 2022 Jun; 12(1):9304. PubMed ID: 35660774
[TBL] [Abstract][Full Text] [Related]
20. Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection.
Choi Q; Hong KH; Kim JE; Kim HK
Ann Lab Med; 2014 Mar; 34(2):85-91. PubMed ID: 24624342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
